Metis Global Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Sell
1,678
-316
-16% -$52.6K 0.01% 653
2026
Q1
$418K Sell
1,994
-243
-11% -$61.1K 0.01% 603
2025
Q4
$636K Sell
2,237
-1,578
-41% -$493K 0.02% 548
2025
Q3
$1.18M Sell
3,815
-27
-0.7% -$8.46K 0.03% 437
2025
Q2
$1.21M Buy
3,842
+230
+6% +$66.4K 0.03% 427
2025
Q1
$949K Buy
3,612
+576
+19% +$156K 0.03% 472
2024
Q4
$793K Buy
3,036
+83
+3% +$20.9K 0.02% 485
2024
Q3
$687K Buy
2,953
+122
+4% +$25.1K 0.02% 505
2024
Q2
$571K Sell
2,831
-1,457
-34% -$263K 0.02% 512
2024
Q1
$735K Buy
4,288
+1,471
+52% +$274K 0.03% 475
2023
Q4
$611K Sell
2,817
-1,317
-32% -$226K 0.02% 501
2023
Q3
$659K Buy
4,134
+836
+25% +$187K 0.03% 474
2023
Q2
$951K Buy
3,298
+121
+4% +$36.8K 0.05% 378
2023
Q1
$1.01M Buy
3,177
+1,442
+83% +$427K 0.07% 325
2022
Q4
$511K Buy
+1,735
New +$479K 0.05% 415

Other funds holding PODD

Metis Global Partners's PODD Position: Q2 2026 in Review

Metis Global Partners reduced its Insulet (PODD) stake by 16% in Q2 2026, selling an estimated $52.6K and leaving 1,678 shares worth $255K. The position accounts for 0.01% of the portfolio, ranked #653.

Metis Global Partners first reported a position in PODD in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.21M in Q2 2025. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Metis Global Partners held 1,678 shares of Insulet worth $255K as of Q2 2026.
  • Metis Global Partners sold 316 Insulet shares in Q2 2026, an estimated $52.6K.
  • Insulet made up 0.01% of Metis Global Partners's portfolio in Q2 2026, its #653 holding.
  • Metis Global Partners first reported a position in Insulet in Q4 2022 and has held it in 15 quarters since.
  • Metis Global Partners's Insulet position peaked at $1.21M in Q2 2025.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.